Evaluation of a new tool, PREDICT: Prostate, to aid treatment decision-making for men with newly diagnosed non-metastatic prostate cancer

Cambridge University Hospitals NHS Foundation Trust0 个研究点目标入组 156 人开始时间: 2018年8月31日最近更新: 2023年10月3日

适应症

试验速览

2021 Results article in https://pubmed.ncbi.nlm.nih.gov/34493413/ (added 08/12/2022)

•1. Men newly diagnosed with primary non-metastatic PCa
•2. Men for whom either active surveillance or radical treatment (prostatectomy +/- radiotherapy) are felt to be appropriate by the diagnosing clinician
•3. Age 35-80 years
•4. Able to understand and sign the written Informed Consent Form

•1. Subject is known to have a condition, which affects their ability to see, read or understand the decision aid
•2. Subject is known to have any other condition, which in the opinion of the investigator makes the subject unsuitable for study participation
•3. The subject is unable to comprehend English. (PREDICT Prostate is only available in English currently)

发起方